YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
10x Genomics, Inc. TXG recently announced a multi-project research collaboration with Fred Hutchinson Cancer Center to advance single-cell and spatial technologies across solid tumors and blood cancers. The collaboration will focus on biom…
Excellent quarterly performance firmly positions Torex to achieve full-year production guidance (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - October 6, 2026) - Torex Gold Resources Inc…
Surging United States Treasury yields have pushed borrowing costs higher worldwide, which puts balance sheet strength back in the spotlight for Canadian investors. When money is no longer cheap, firms with solid finances and lower risk sco…
Torex Gold Resources Inc. recently reported strong drilling and exploration results across the Morelos Property, including the San Miguel corridor, Media Luna, ELG Underground, and regional targets such as Atzcala and El Naranjo, reinforci…
10x Genomics, Inc. TXG recently began commercial shipments of Atera, its next-generation spatial biology platform designed to combine whole-transcriptome analysis, sub-cellular resolution and single-cell sensitivity at scale. The launch ma…
Healthcare stocks rose late Monday afternoon with the NYSE Healthcare Index and the State Street Hea PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Cathie Wood’s Ark Invest boosted its technology, biotechnology, and space exposure last week, led by purchases of more than 51K shares of Meta Platforms (META [https://seekingalpha.com/symbol/META]) worth $38.2M and roughly 360K shares of…
Canadian investors are watching global bond markets reset as government yields climb to two decade highs, pushing up borrowing costs for everything from mortgages to corporate debt. When money becomes more expensive, fragile balance sheets…
Torex Gold Resources (TSX:TXG) just reported fresh drilling results from its Morelos property, highlighting continuous mineralization along the San Miguel corridor and active programs aimed at reserve definition and potential mine life ext…
San Miguel corridor shows strong potential to significantly add to resource profile (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - September 24, 2026) - Torex Gold Resources Inc. (the "C…
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as…
3 Russell 2000 Stocks That Fall Short The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher vola…
This article first appeared on GuruFocus. Cathie Wood's Ark Invest made a sharp rotation across technology and biotechnology stocks last week, buying roughly $28 million of Meta Platforms (NASDAQ:META) while selling a nearly identical doll…
Cathie Wood, head of Ark Investment Management, often buys her favorite tech stocks when she sees a new opportunity. That's what she did last week, pouring $27.9 million into Meta Platforms (META) as the company pushes deeper into AI. Last…
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know What Happened? A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader…
Company Logo The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker deve…
Cathie Wood, chief of Ark Investment Management, likes to chase momentum in her favorite tech bets. This week, she's buying $6.5 million of Cerebras stock as the AI chip stock surges. Last year, the flagship Ark Innovation ETF gained 35.49…
A month has gone by since the last earnings report for Hims & Hers Health, Inc. (HIMS). Shares have lost about 7.7% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continu…
(1:00) - What Is mRNA? Why Was The Breakthrough So Important? (4:30) - What Is The Difference Between Personalized And Traditional Cancer Treatments? (7:20) - How Close Is the Approval And Could It Work For Different Types of Cancer? (9:15…
Company Logo 578-Page Report Forecasts Market Growth from $3.18B (2026) to $5.7B by 2031, Profiling 10x Genomics, Thermo Fisher, Illumina, Oxford Nanopore, Bruker, and 14 Other Key Players Multiomics MarketMultiomics Market Dublin, Sept. 0…
[Bitcoin 2022 Conference Draws Cryptocurrency Industry Professionals And Investors To Miami] Marco Bello/Getty Images News Cathie Wood’s Ark Invest leaned further into high-growth themes, including space, fintech, crypto, and biotechnology…
3 Inflated Stocks with Open Questions The stocks featured in this article are seeing some big returns. Over the past month, they've outpaced the market due to some combination of positive news, upbeat results, or supportive macro developme…
10x Genomics, Inc. TXG has surged 84% in the past three months, putting pressure on its fundamentals to keep pace with the stock. Consumables growth, Atera demand and a higher 2026 outlook provide support. Weak instrument sales, operating…
10x Genomics, Inc. TXG recently secured a favorable jury verdict in its patent infringement case against Parse Biosciences, a Qiagen QGEN subsidiary. The Delaware jury found Parse infringed three patents licensed to Scale Biosciences, uphe…
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2026) - iMetal Resources Inc. (TSXV: IMR) (OTCQB: IMRFF) (FSE: A7VA) ("iMetal" or the "Company") is pleased to announce the appointment of Paul Larkin as an independent director and…
Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index and the State Str PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
[Wooden cubes forming the word PATENT on a document, legal and intellectual property concept.] * Qiagen (QGEN [https://seekingalpha.com/symbol/QGEN]) subsidiary Parse Biosciences will be forced to pay more than $4.8M in damages after a jur…
Jury finds Parse willfully infringed Scale Biosciences' patents and rejects Parse's invalidity challenge PLEASANTON, Calif., Aug. 28, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on acce…
Winners And Losers Of Q2: Illumina (NASDAQ:ILMN) Vs The Rest Of The Life Sciences Tools & Services Stocks Looking back on life sciences tools & services stocks' Q2 earnings, we examine this quarter's best and worst performers, including Il…
3 Small-Cap Stocks with Open Questions Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside ri…
Cathie Wood, head of Ark Investment Management, often adds to her favorite tech stocks when prices swing. This week, she's buying SpaceX (SPCX), continuing to build her position after the newly public stock went through a volatile stretch…
On August 6, 10x Genomics (NASDAQ:TXG) reported second-quarter revenue of $151 million, boosted by a $1.6 million settlement payment from Takara. Strip that out and revenue grew just 3% year-over-year to $149.4 million, a modest number nex…
1 High-Flying Stock to Own for Decades and 2 We Question Expensive stocks typically earn their valuations through superior growth rates that other companies simply can't match. The flip side though is that these lofty expectations make the…
1 Unpopular Stock That Deserves Some Love and 2 That Underwhelm Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate rela…
Key Points Interested in 10x Genomics? Here are five stocks we like better. Atera demand is strong ahead of launch: Booked orders by the end of Q2 exceeded the approximately 40 systems 10x Genomics expects to ship in 2026, with production…
10x Genomics TXG reported a second-quarter 2026 loss of 14 cents per share against earnings of 28 cents in the year-ago quarter, representing a 150% year-over-year decline. Still, the figure beat the Zacks Consensus Estimate of a loss of 2…